StockWatch
·
Biotechnology: Commercial Physical & Biological Resarch
Corporate ActionJul 17, 2026, 06:07 AM

iSpecimen Announces Public Offering of Up to 2.09M Shares & Warrants

AI Summary

iSpecimen Inc. filed an amendment for a proposed public offering of up to 2,092,050 shares of common stock and an equal number of pre-funded warrants, with an assumed public offering price of $2.39 per share. This follows a May 2026 private placement that raised approximately $2.5 million gross proceeds. The company also noted two recent reverse stock splits, 1-for-20 in September 2024 and 1-for-40 in April 2026.

Key Highlights

  • Proposed public offering of up to 2,092,050 common shares.
  • Proposed public offering of up to 2,092,050 pre-funded warrants.
  • Assumed public offering price of $2.39 per common share.
  • May 2026 private placement raised $2.5 million gross proceeds.
  • Private placement issued 488,281 shares/pre-funded warrants.
  • Reverse stock split of 1-for-20 effected on September 13, 2024.
  • Reverse stock split of 1-for-40 effected on April 27, 2026.
  • Placement agent fee of 4% of gross proceeds for the offering.